Biotech Firm Claims Some Credit for Groundbreaking Virus Research
Radical Numerics turned heads with its announcement about a novel treatment. Now a former partner, Tabula Bioscience, says it performed much of the research.
Lean: Left
Fact-focusedFactuality: Very highCountry: United StatesFunding: PrivateOwner: NY Times Company
Coverage breakdown
Funding
Private100%
Countries
United States100%
Media ownership
NY Times Company100%
Avg reliability88
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 46 (Limited corroboration)
Propaganda risk: 0
Trending: Low
Sources: 1
Reliability: 88
Bias severity: 0
Risk: 0Sentiment: 0Sensationalism: 0
Amplification: 0
